Estradiol valerate + Progesterone

Estradiol valerate + progesterone is a combination hormone therapy used primarily to treat menopausal symptoms. This combination consists of estradiol valerate, an estrogen, and progesterone, a progestin hormone. ## Formulation and Brand Names The combination of estradiol valerate and progesterone is available as an oral medication. One notable brand name for a similar combination (though using estradiol rather than estradiol valerate specifically with progesterone) is Bijuva, which is described as the first and only FDA-approved combination of bio-identical estradiol and bio-identical progesterone in a single daily oral capsule[9]. ## Medical Uses This hormone combination is primarily used for: - Treatment of moderate to severe vasomotor symptoms associated with menopause (hot flashes, night sweats)[1][3] - Treatment of vulvovaginal atrophy symptoms (vaginal dryness, irritation)[6] - Prevention of osteoporosis in menopausal women[3] ## Mechanism of Action Estradiol valerate is an esterified form of natural 17β-estradiol, which is hydrolyzed to estradiol soon after oral administration. Estradiol is the most potent endogenous human ovarian estrogen[8]. Progesterone is added to estrogen therapy in women who still have their uterus to reduce the risk of uterine cancer that can occur with unopposed estrogen therapy[3]. The combination works by: - Replacing estrogen hormones no longer produced by the body during menopause - Reducing hot flashes and night sweats - Improving vaginal symptoms like dryness and irritation - Preventing bone loss (osteoporosis) - Progesterone component protects the uterine lining from excessive growth that could lead to cancer ## Administration For oral formulations like Bijuva, the medication is typically taken once daily[3]. The dosing schedule should be followed exactly as prescribed by a healthcare provider. ## Side Effects and Risks Common side effects may include: - Breast tenderness or enlargement - Nausea and headache - Fluid retention - Vaginal bleeding or spotting Important safety considerations include: - Increased risk of endometrial cancer (though reduced by the progesterone component) - Cardiovascular risks including heart attack, stroke, and blood clots - Potential worsening of certain conditions like high blood pressure, diabetes, asthma, and migraines[10] ## Contraindications This medication should not be used in women with: - Undiagnosed abnormal genital bleeding - Known or suspected breast cancer or estrogen-dependent neoplasia - Active deep vein thrombosis, pulmonary embolism, or history of these conditions - Active or recent arterial thromboembolic disease - Liver dysfunction or disease - Known hypersensitivity to ingredients - Pregnancy[6] Healthcare providers should carefully evaluate the risks and benefits of hormone therapy for each individual patient, with regular follow-up appointments to assess ongoing treatment needs.